OPEN END TURBO OPTIONSSCHEIN - EDWARDS LIFESCIENCES | Market Closed - Börse Stuttgart 15:58:51 2024-05-31 EDT | ||
| 1.18 EUR | +9.26% |
|
| 1 month | -16.90% | ||
| 3 months | -12.59% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-05-31 | 1.18 | +9.26% |
| 24-05-30 | 1.08 | -10.74% |
| 24-05-29 | 1.21 | +3.42% |
| 24-05-28 | 1.17 | +10.38% |
| 24-05-27 | 1.06 | -1.85% |
Delayed Quote Börse Stuttgart
Last update May 31, 2024 at 03:58 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | J.P. Morgan |
| WKN | JQ49W0 |
| ISIN | DE000JQ49W08 |
| Date issued | 2022-08-25 |
| Strike | 99.49 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.64 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.57 € |
|---|---|
| Lowest since issue | 0.3 € |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
86.89
USD
Average target price
96.55
USD
Spread / Average Target
+11.12%
- Stock Market
- Certificates
- Certificat
